Cargando…

Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma

This study focused on the expression of mitochondrial serine hydroxymethyltransferase (SHMT2) in oral squamous cell carcinoma (OSCC) and its correlation with clinical traits and the prognosis of OSCC patients. Immunochemical staining and Western blotting were used to quantify the expression of SHMT2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhi-Zhong, Wang, Shuo, Yang, Qi-Chao, Wang, Xiao-Long, Yang, Lei-Lei, Liu, Bing, Sun, Zhi-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581701/ https://www.ncbi.nlm.nih.gov/pubmed/33163414 http://dx.doi.org/10.3389/fonc.2020.588530

Ejemplares similares

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma
por: Kong, Weiyu, et al.
Publicado: (2022)

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
por: Zhang, Peng, et al.
Publicado: (2021)

Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT
por: Na, Sijia, et al.
Publicado: (2022)

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Wang, Mingyue, et al.
Publicado: (2019)

FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis
por: Zheng, Yi-Wen, et al.
Publicado: (2020)

ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma
por: Zhang, Shuo, et al.
Publicado: (2021)

High CBX8 Expression Leads to Poor Prognosis in Laryngeal Squamous Cell Carcinoma by Inducing EMT by Activating the Wnt/β-Catenin Signaling Pathway
por: Meng, Qingchao, et al.
Publicado: (2022)

IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
por: Jiao, Ruidi, et al.
Publicado: (2020)

SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
por: Anderson, Donald D., et al.
Publicado: (2009)

Circular RNA Expression in Oral Squamous Cell Carcinoma
por: Wang, Yu-Fan, et al.
Publicado: (2018)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
por: Zhou, Suna, et al.
Publicado: (2021)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer
por: Li, Jun, et al.
Publicado: (2023)

Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma
por: Shao, Jing‐Xin, et al.
Publicado: (2016)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
por: Chen, Xiao-Yong, et al.
Publicado: (2022)

GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma
por: Chen, Nan, et al.
Publicado: (2023)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy
por: Yang, Xue, et al.
Publicado: (2023)

CD163+ Tumor-Associated Macrophages Correlated with Poor Prognosis and Cancer Stem Cells in Oral Squamous Cell Carcinoma
por: He, Ke-Fei, et al.
Publicado: (2014)

TGFBI Promotes Tumor Growth and is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Bing-jie, et al.
Publicado: (2019)

Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
por: Liao, Yan, et al.
Publicado: (2021)

Correlation Between TCF7(+) T Cells and Prognosis of Patients With Oral Squamous Cell Carcinoma
por: Rong, Haixu, et al.
Publicado: (2022)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
por: Kang, Jin, et al.
Publicado: (2020)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
por: Zhong, Bin-Yan, et al.
Publicado: (2020)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China
por: Lei, Ling-Ling, et al.
Publicado: (2023)

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers
por: Zhang, Ling, et al.
Publicado: (2021)

Progression of Intravesical Condyloma Acuminata to Locally Advanced Poorly Differentiated Squamous Cell Carcinoma
por: Khambati, A., et al.
Publicado: (2016)

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma
por: Yi, Xiaoping, et al.
Publicado: (2021)

Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade
por: Zhu, Dong-wang, et al.
Publicado: (2013)

USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance
por: Jin, RuiRi, et al.
Publicado: (2023)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tj2p7e0jnl10cr8bvc7mbg083i